PELI1: A Promising Therapeutic Target to Overcome Chronic Myeloid Leukaemia Resistance
For two decades, the treatment of chronic myeloid leukaemia (CML) has been viewed as one of the greatest success stories in modern oncology. The introduction of … Read more